PTC THERAPEUTICS, INC. Earnings Per Share Diluted

Quick Answer

PTC THERAPEUTICS, INC. reported Earnings Per Share Diluted of $7.78 per share for the year ending 2025.

  • PTC THERAPEUTICS, INC. showed an increase of +264.5% in Earnings Per Share Diluted from 2024 to 2025.
  • This data is from PTC THERAPEUTICS, INC.'s annual report (Form 10-K), filed with the SEC on February 19, 2026.
  • XBRL data for this metric is available from 2011 to 2025 (11 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 11 years of available data (2011 to 2025), PTC THERAPEUTICS, INC.'s Earnings Per Share Diluted has grown by 71.0%.
  • Historical annual values: Fiscal year 2025: $7.78 per share | Fiscal year 2024: $4.73 (loss) per share | Fiscal year 2023: $8.37 (loss) per share | Fiscal year 2022: $7.79 (loss) per share | Fiscal year 2021: $7.43 (loss) per share | Fiscal year 2020: $6.64 (loss) per share | Fiscal year 2019: $4.27 (loss) per share | Fiscal year 2014: $2.97 (loss) per share | Fiscal year 2013: $5.18 (loss) per share | Fiscal year 2012: $42.50 per share | Fiscal year 2011: $4.55 per share.
  • Data sourced from SEC EDGAR public filings as of June 22, 2026.

Last verified: